Linear ubiquitination induces NEMO phase separation to activate NF-κB signaling.


Journal

Life science alliance
ISSN: 2575-1077
Titre abrégé: Life Sci Alliance
Pays: United States
ID NLM: 101728869

Informations de publication

Date de publication:
04 2023
Historique:
received: 15 07 2022
revised: 09 01 2023
accepted: 09 01 2023
entrez: 31 1 2023
pubmed: 1 2 2023
medline: 3 2 2023
Statut: epublish

Résumé

The NF-κB essential modulator NEMO is the core regulatory component of the inhibitor of κB kinase complex, which is a critical checkpoint in canonical NF-κB signaling downstream of innate and adaptive immune receptors. In response to various stimuli, such as TNF or IL-1β, NEMO binds to linear or M1-linked ubiquitin chains generated by LUBAC, promoting its oligomerization and subsequent activation of the associated kinases. Here we show that M1-ubiquitin chains induce phase separation of NEMO and the formation of NEMO assemblies in cells after exposure to IL-1β. Phase separation is promoted by both binding of NEMO to linear ubiquitin chains and covalent linkage of M1-ubiquitin to NEMO and is essential but not sufficient for its phase separation. Supporting the functional relevance of NEMO phase separation in signaling, a pathogenic NEMO mutant, which is impaired in both binding and linkage to linear ubiquitin chains, does not undergo phase separation and is defective in mediating IL-1β-induced NF-κB activation.

Identifiants

pubmed: 36720498
pii: 6/4/e202201607
doi: 10.26508/lsa.202201607
pmc: PMC9889916
pii:
doi:

Substances chimiques

NF-kappa B 0
I-kappa B Kinase EC 2.7.11.10
Ubiquitin 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2023 Goel et al.

Références

Nature. 2012 Mar 07;483(7389):336-40
pubmed: 22398450
Annu Rev Biophys. 2019 May 6;48:465-494
pubmed: 30951647
J Biol Chem. 2021 Jul;297(1):100860
pubmed: 34102212
J Mol Biol. 2020 Jan 3;432(1):160-169
pubmed: 31260696
Cell. 2013 Feb 14;152(4):791-805
pubmed: 23415227
Mol Cell. 2009 Mar 13;33(5):602-15
pubmed: 19185524
Cell Res. 2018 Apr;28(4):405-415
pubmed: 29507397
Biochemistry. 2018 May 1;57(17):2478-2487
pubmed: 29517898
Cell Death Differ. 2021 Feb;28(2):473-492
pubmed: 33441937
Genes Dev. 2012 Feb 1;26(3):203-34
pubmed: 22302935
Cell Rep. 2016 Mar 29;14(12):2846-58
pubmed: 26997266
Curr Biol. 2022 Jun 6;32(11):R506-R508
pubmed: 35671719
Science. 2021 Jun 25;372(6549):eabf6548
pubmed: 34739333
Cold Spring Harb Perspect Biol. 2010 Mar;2(3):a000158
pubmed: 20300203
Curr Biol. 2004 Dec 29;14(24):2217-27
pubmed: 15620648
Nature. 2013 Jun 20;498(7454):318-24
pubmed: 23708998
Matrix Biol. 2021 Jun;100-101:9-22
pubmed: 33259919
Front Chem. 2020 Jan 10;7:915
pubmed: 31998699
Nat Rev Immunol. 2015 Jun;15(6):362-74
pubmed: 26008591
Mol Cell. 2018 Mar 15;69(6):965-978.e6
pubmed: 29526694
Science. 2016 Apr 29;352(6285):595-9
pubmed: 27056844
Biochem Soc Trans. 2022 Apr 29;50(2):799-811
pubmed: 35343567
Mol Cell. 2009 Dec 11;36(5):831-44
pubmed: 20005846
J Biol Chem. 2015 May 29;290(22):14130-9
pubmed: 25866210
J Biol Chem. 2019 May 3;294(18):7115-7127
pubmed: 30045872
Cell. 2013 Apr 11;153(2):287-92
pubmed: 23582320
Mol Cell. 2013 Jun 27;50(6):818-830
pubmed: 23806334
Nature. 2000 May 25;405(6785):466-72
pubmed: 10839543
Nature. 2004 Jan 8;427(6970):167-71
pubmed: 14695475
Hum Mutat. 2014 Feb;35(2):165-77
pubmed: 24339369
Nat Cell Biol. 2006 Apr;8(4):398-406
pubmed: 16547522
Mol Cell. 2022 Jul 7;82(13):2415-2426.e5
pubmed: 35477005
EMBO J. 2022 Dec 15;41(24):e112006
pubmed: 36398858
Sci Rep. 2020 May 15;10(1):8074
pubmed: 32415277
Mol Cell. 2019 Apr 18;74(2):330-346.e11
pubmed: 30853400
Trends Mol Med. 2017 Dec;23(12):1138-1155
pubmed: 29128367
J Biol Chem. 2012 Jul 6;287(28):23626-34
pubmed: 22605335
Mol Cell. 2000 Jun;5(6):981-92
pubmed: 10911992
Mol Cell. 2006 Apr 21;22(2):245-57
pubmed: 16603398
Biochem Soc Trans. 2021 Feb 26;49(1):365-377
pubmed: 33634825
J Cell Sci. 2018 Oct 4;131(19):
pubmed: 30287680
Nat Commun. 2016 Sep 02;7:12629
pubmed: 27586688
Science. 2017 Sep 22;357(6357):
pubmed: 28935776
Mol Cell. 2013 Mar 7;49(5):908-21
pubmed: 23453807
Proc Natl Acad Sci U S A. 2013 Sep 17;110(38):15247-52
pubmed: 23986494
Nat Rev Mol Cell Biol. 2013 Oct;14(10):673-85
pubmed: 23989959
Cell. 2009 Mar 20;136(6):1098-109
pubmed: 19303852
EMBO J. 2009 Oct 7;28(19):2885-95
pubmed: 19763089
Nat Immunol. 2002 Mar;3(3):221-7
pubmed: 11875461
Int J Mol Sci. 2020 May 11;21(9):
pubmed: 32403254
Immunol Rev. 2012 Mar;246(1):77-94
pubmed: 22435548
Mol Cell. 2015 Apr 16;58(2):362-70
pubmed: 25801169
Cell. 2003 Nov 26;115(5):565-76
pubmed: 14651848
Cells. 2021 Oct 09;10(10):
pubmed: 34685685
Int Rev Immunol. 2015;34(6):445-59
pubmed: 26269396
Bioessays. 2020 Nov;42(11):e2000036
pubmed: 32881044
EMBO Rep. 2012 Sep;13(9):840-6
pubmed: 22791023
Cell. 2013 Jun 6;153(6):1312-26
pubmed: 23746843
EMBO Rep. 2009 May;10(5):466-73
pubmed: 19373254
Dev Cell. 2020 Oct 12;55(1):45-68
pubmed: 33049211
Mol Biotechnol. 2012 Jul;51(3):254-61
pubmed: 22012022
EMBO J. 2006 Oct 18;25(20):4877-87
pubmed: 17006537
Structure. 2019 Jun 4;27(6):937-951.e5
pubmed: 30982635
Nucleic Acids Res. 2007;35(6):e45
pubmed: 17317681
Trends Mol Med. 2018 Jan;24(1):49-65
pubmed: 29217118
J Cell Biol. 2014 Jan 20;204(2):231-45
pubmed: 24446482
Cell Death Differ. 2021 Feb;28(2):557-569
pubmed: 33473179
Sci Adv. 2020 Oct 14;6(42):
pubmed: 33055165
Semin Immunol. 2014 Jun;26(3):253-66
pubmed: 24958609
Nat Cell Biol. 2009 Feb;11(2):123-32
pubmed: 19136968
Biochem Biophys Res Commun. 2016 Jun 3;474(3):452-461
pubmed: 27133719
Mol Cell Biol. 2014 Apr;34(7):1322-35
pubmed: 24469399
Cytokine. 2018 Jan;101:26-32
pubmed: 27623350
EMBO J. 2018 Mar 1;37(5):
pubmed: 29343546
Annu Rev Biophys. 2013;42:443-68
pubmed: 23495970
Cell Death Differ. 2017 Jul;24(7):1153-1159
pubmed: 28475177
Sci Rep. 2022 Jul 18;12(1):12241
pubmed: 35851409
Science. 2018 Aug 17;361(6403):704-709
pubmed: 29976794
Sci Rep. 2016 Jan 07;6:18934
pubmed: 26740240
Nature. 2011 Mar 31;471(7340):637-41
pubmed: 21455181
J Cell Sci. 2019 Jan 18;132(2):
pubmed: 30659056
Mol Cell. 2022 Jun 16;82(12):2201-2214
pubmed: 35675815
FEBS Lett. 2009 Oct 20;583(20):3317-22
pubmed: 19766637
Annu Rev Genet. 2019 Dec 3;53:171-194
pubmed: 31430179
Chem Commun (Camb). 2021 Dec 9;57(98):13275-13287
pubmed: 34816836
Nat Commun. 2019 Sep 20;10(1):4320
pubmed: 31541095
Annu Rev Biophys. 2020 May 6;49:107-133
pubmed: 32004090

Auteurs

Simran Goel (S)

Department Molecular Cell Biology, Institute of Biochemistry and Pathobiochemistry, Ruhr University Bochum, Bochum, Germany.

Rosario Oliva (R)

Physical Chemistry I-Biophysical Chemistry, Department of Chemistry and Chemical Biology, TU Dortmund University, Dortmund, Germany.
Department of Chemical Sciences, University of Naples Federico II, Naples, Italy.

Sadasivam Jeganathan (S)

Department Molecular Cell Biology, Institute of Biochemistry and Pathobiochemistry, Ruhr University Bochum, Bochum, Germany.

Verian Bader (V)

Department Molecular Cell Biology, Institute of Biochemistry and Pathobiochemistry, Ruhr University Bochum, Bochum, Germany.
Department Biochemistry of Neurodegenerative Diseases, Institute of Biochemistry and Pathobiochemistry, Ruhr University Bochum, Bochum, Germany.

Laura J Krause (LJ)

Department Molecular Cell Biology, Institute of Biochemistry and Pathobiochemistry, Ruhr University Bochum, Bochum, Germany.
RESOLV Cluster of Excellence, Ruhr University Bochum, Bochum, Germany.

Simon Kriegler (S)

Physical Chemistry I-Biophysical Chemistry, Department of Chemistry and Chemical Biology, TU Dortmund University, Dortmund, Germany.

Isabelle D Stender (ID)

Protein Chemistry Facility, Max Planck Institute of Molecular Physiology, Dortmund, Germany.

Chadwick W Christine (CW)

Department of Neurology, UCSF, San Francisco, CA, USA.

Ken Nakamura (K)

Department of Neurology, UCSF, San Francisco, CA, USA.
Gladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA, USA.

Jan-Erik Hoffmann (JE)

Protein Chemistry Facility, Max Planck Institute of Molecular Physiology, Dortmund, Germany.

Roland Winter (R)

Physical Chemistry I-Biophysical Chemistry, Department of Chemistry and Chemical Biology, TU Dortmund University, Dortmund, Germany.
RESOLV Cluster of Excellence, Ruhr University Bochum, Bochum, Germany.

Jörg Tatzelt (J)

RESOLV Cluster of Excellence, Ruhr University Bochum, Bochum, Germany konstanze.winklhofer@ruhr-uni-bochum.de joerg.tatzelt@rub.de.
Department Biochemistry of Neurodegenerative Diseases, Institute of Biochemistry and Pathobiochemistry, Ruhr University Bochum, Bochum, Germany.

Konstanze F Winklhofer (KF)

Department Molecular Cell Biology, Institute of Biochemistry and Pathobiochemistry, Ruhr University Bochum, Bochum, Germany konstanze.winklhofer@ruhr-uni-bochum.de joerg.tatzelt@rub.de.
RESOLV Cluster of Excellence, Ruhr University Bochum, Bochum, Germany.

Articles similaires

The FGF/FGFR/c-Myc axis as a promising therapeutic target in multiple myeloma.

Arianna Giacomini, Sara Taranto, Giorgia Gazzaroli et al.
1.00
Humans Multiple Myeloma Receptors, Fibroblast Growth Factor Fibroblast Growth Factors Proto-Oncogene Proteins c-myc
Animals Lung India Sheep Transcriptome

Calcineurin inhibition enhances

Priyanka Das, Alejandro Aballay, Jogender Singh
1.00
Animals Caenorhabditis elegans Longevity Caenorhabditis elegans Proteins Calcineurin
1.00
Animals Mice Immunity, Innate Interneurons Synapses

Classifications MeSH